Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome

References

• Quercioli A, Mach F, Montecucco F. Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 2010;14(3):261–9.
   PubMed Web of Science ®Google Scholar
• Oktay B, Akbal E, Firat H, et al. Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome. Sleep Breath 2008;12(3):223–8.
   PubMed Web of Science ®Google Scholar
• Ozben S, Guvenc TS, Huseyinoglu N, et al. Low serum copeptin levels in patients with obstructive sleep apnea. Sleep Breath 2013;17(4):1187–92.
   PubMed Web of Science ®Google Scholar
• Petrosyan M, Perraki E, Simoes D, et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath 2008;12(3):207–15.
   PubMed Web of Science ®Google Scholar
• Ursavas A, Karadag M, Gullulu M, et al. Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients. Sleep Breath 2008;12(3):217–22.
   PubMed Web of Science ®Google Scholar
• Khassawneh B, Ghazzawi M, Khader Y, et al. Symptoms and risk of obstructive sleep apnea in primary care patients in Jordan. Sleep Breath 2009;13(3):227–32.
   PubMed Web of Science ®Google Scholar
• Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112(17):2660–7.
   PubMed Web of Science ®Google Scholar
• Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91(11):988–98.
   PubMed Web of Science ®Google Scholar
• Diez-Ruiz A, Tilz GP, Zangerle R, et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54(1):1–8.
   PubMed Web of Science ®Google Scholar
• Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008;32(4):1009–15.
   PubMed Web of Science ®Google Scholar
• Dibbs Z, Thornby J, White BG, et al. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 1999;33(7):1935–42.
   PubMed Web of Science ®Google Scholar
• Loria V, Dato I, Graziani F, et al. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008;2008:135625.
   PubMed Web of Science ®Google Scholar
• Yonezawa K, Morimoto N, Matsui K, et al. Significance of the neutrophil myeloperoxidase index in patients with atherosclerotic diseases. Kobe J Med Sci 2012;58(5):E128–37.
   Google Scholar
• Akpinar ME, Yigit O, Altundag A, et al. Salivary and serum myeloperoxidase in obstructive sleep apnea. J Otolaryngol Head Neck Surg 2012;41(3):215–21.
   PubMed Web of Science ®Google Scholar
• Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22(5):667–89.
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560–72.
   PubMed Web of Science ®Google Scholar
• Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults–The Evidence Report. National Institutes of Health. Obes Res 1998;6 Suppl 2:51S–209S.
   PubMedGoogle Scholar
• Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62–9.
   PubMed Web of Science ®Google Scholar
• Krueger AJ, Yang JJ, Roy TA, et al. An automated myeloperoxidase assay. Clin Chem 1990;36(1):158.
   PubMed Web of Science ®Google Scholar
• Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006;174(7):824–30.
   PubMed Web of Science ®Google Scholar
• Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107(8):1129–34.
   PubMed Web of Science ®Google Scholar
• Butt M, Khair OA, Dwivedi G, et al. Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea. Hypertension 2011;58(3):417–24.
   PubMed Web of Science ®Google Scholar
• Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011;140(2):534–42.
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Stafforini DM. Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res 2012;53(9):1767–82.
   PubMed Web of Science ®Google Scholar
• Vrints H, Shivalkar B, Hilde H, et al. Cardiovascular mechanisms and consequences of obstructive sleep apnoea. Acta Clin Belg 2013;68(3):169–78.
   PubMed Web of Science ®Google Scholar
• Haensel A, Bardwell WA, Mills PJ, et al. Relationship between inflammation and cognitive function in obstructive sleep apnea. Sleep Breath 2009;13(1):35–41.
   PubMed Web of Science ®Google Scholar
• Svensson M, Venge P, Janson C, et al. Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res 2012;21(2):147–54.
   PubMed Web of Science ®Google Scholar
• Ciftci TU, Kokturk O, Bukan N, et al. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004;28(2):87–91.
   PubMed Web of Science ®Google Scholar
• Can M, Acikgoz S, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006;129(2):233–7.
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Tamaki S, Tomoda K, et al. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath 2006;10(4):189–93.
   PubMed Web of Science ®Google Scholar
• Ryan S, Nolan GM, Hannigan E, et al. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 2007;62(6):509–14.
   PubMed Web of Science ®Google Scholar
• Imagawa S, Yamaguchi Y, Ogawa K, et al. Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration 2004;71(1):24–9.
   PubMed Web of Science ®Google Scholar
• Kunz AB, Kraus J, Young P, et al. Biomarkers of inflammation and endothelial dysfunction in stroke with and without sleep apnea. Cerebrovasc Dis 2012;33(5):453–60.
   PubMed Web of Science ®Google Scholar
• Baguet JP, Barone-Rochette G, Tamisier R, et al. Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol 2012;9(12):679–88.
   PubMed Web of Science ®Google Scholar
• Jelic S, Le Jemtel TH. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med 2008;18(7):253–60.
   PubMed Web of Science ®Google Scholar
• Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103(16):2055–9.
   PubMed Web of Science ®Google Scholar
• Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000;102(25):3060–7.
   PubMed Web of Science ®Google Scholar
• Ueland T, Kjekshus J, Froland SS, et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol 2005;46(11):2018–21.
   PubMed Web of Science ®Google Scholar
• Maki-Petaja KM, Elkhawad M, Cheriyan J, et al. Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 2012;126(21):2473–80.
   PubMed Web of Science ®Google Scholar
• Jacobsson LT, Turesson C, Gulfe A, et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005;32(7):1213–8.
   PubMed Web of Science ®Google Scholar
• Ciccone MM, Scicchitano P, Zito A, et al. Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in Obstructive Sleep Apnea. Molecules 2014;19(2):1651–62.
   PubMed Web of Science ®Google Scholar
• Minoguchi K, Tazaki T, Yokoe T, et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004;126(5):1473–9.
   PubMed Web of Science ®Google Scholar
• Ohga E, Tomita T, Wada H, et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol (1985) 2003;94(1):179–84.
   PubMed Web of Science ®Google Scholar
• Xie X, Pan L, Ren D, et al. Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: A meta-analysis. Sleep Med 2013;14(11):1139–50.
   PubMed Web of Science ®Google Scholar
• Ryan S, Taylor CT, McNicholas WT. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009;64(7):631–6.
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 2008;38(8):585–95.
   PubMed Web of Science ®Google Scholar
• Sirpal S. Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease. Clin Sci (Lond) 2009;116(9):681–95.
   PubMed Web of Science ®Google Scholar
• Mocatta TJ, Pilbrow AP, Cameron VA, et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007;49(20):1993–2000.
   PubMed Web of Science ®Google Scholar
• Tang WH, Wu Y, Nicholls SJ, et al. Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease. Clin Chem 2011;57(1):33–9.
   PubMed Web of Science ®Google Scholar
• Meuwese MC, Stroes ES, Hazen SL, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50(2):159–65.
   PubMed Web of Science ®Google Scholar